Business Wire

Solidus Labs Unveils Agentic-Based Compliance: A New Model for Trade Surveillance Operations

22.5.2025 14:00:00 CEST | Business Wire | Press Release

Share

Solidus Labs, the category-definer in trade surveillance and risk monitoring for digital and traditional asset classes, today announced the launch of Agentic-Based Compliance, a groundbreaking model for surveillance operations that leverages a network of AI agents to deliver exponential efficiency, precision, and intelligence across the entire trade surveillance and transaction monitoring investigation lifecycle.

Legacy compliance solutions have failed to keep up with the rapid modernization and growing complexity of global markets. Compliance teams are forced to work with a patchwork of disconnected and expensive tools that fail to deliver results efficiently. According to McKinsey, compliance analysts spend 80% of their time on low or moderate-risk issues, often repetitively resolving false positives or performing menial work. This inefficiency extends to market abuse detection: Despite the enormous resources and efforts invested in compliance technology, firms continue to face enforcement actions for missed manipulation. Research shows that market abuse like insider trading occurs in 20% of mergers and acquisitions and 5% of quarterly earnings announcements in U.S. markets. More broadly, only 4% of Suspicious Activity Reports (SARs) lead to law enforcement investigations. This isn’t a failure of effort - it’s a failure of architecture.

Built on Solidus’ proprietary platform, HALO, Agentic-Based Compliance reimagines how financial institutions detect, investigate, and resolve market abuse risks. It replaces legacy systems and siloed workflows with a unified, intelligence-led architecture powered by autonomous AI agents that augment human analysts and operate across a multi-dimensional risk environment.

“Agentic-Based Compliance is the only way compliance teams can stay ahead of emerging complexities like 24/7 off-platform trading, enhanced retail participation and the heightened risks they carry for cyber-enhanced financial crimes and cross-product and cross-market manipulation,” said Asaf Meir, Founder and Chief Executive of Solidus Labs. “Our vision is simple: Compliance operations should be as scalable, intelligent, and efficient as the markets they’re designed to protect. Solidus’ Agentic-Based Compliance delivers just that, solving for tech sprawl, alert fatigue, talent shortage and surveillance blind spots that cost firms thousands of hours and can reach billions of dollars in losses and fines.”

HALO embeds a fleet of purpose-built AI agents, each designed to streamline a specific stage of the compliance investigation lifecycle — from signal enrichment and alert remediation to model testing, OSINT intelligence feeds, case management, and regulatory reporting.

Born in crypto’s highly fragmented and complex environment, Solidus’ Agentic-Based Compliance is future-proof by design for all asset classes, leading to 20X faster investigations and saving compliance analysts as much as 5 hours of menial work per day. Like all Solidus Labs’ solutions, it was developed in tandem with regulatory feedback - aligning with the current and evolving demands of modern financial markets, including the imperatives of market abuse regulations in the U.S., EU, and other leading jurisdictions.

Poised to power the next generation of surveillance operations, Solidus’ Agentic-Based Compliance is already gaining traction among forward-looking financial firms seeking to modernize their compliance capabilities and reduce operational strain.

To learn more, visit www.soliduslabs.com.

About Solidus Labs

Solidus Labs is the category-definer for Agentic-Based Compliance in trade surveillance and risk monitoring. Founded in 2018 by Goldman Sachs veterans, the company merges Wall Street rigor, crypto-native innovation, and cybersecurity principles to reinvent compliance for the modern financial era. At the core is HALO, an AI-powered risk-based platform trusted by financial institutions, crypto firms, and regulators globally to drive proactive, intelligence-led oversight — across any product, venue, or asset class.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250522186908/en/

Contacts

Trevor Davis
Gregory FCA for Solidus Labs
443.248.0359
trevor@gregoryfca.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press Release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 16:25:00 CEST | Press Release

Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press Release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press Release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press Release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye